Dr. Seigo Izumo is Senior Vice President, Global Head of Regenerative Medicine Unit and Head of Scientific Affairs in Japan at Takeda Pharmaceutical Company. Previously he served as Senior VP & Head of Cardiovascular Therapeutics at Gilead Sciences, and VP & Global Head of Cardiovascular Research at Novartis. Prior to joining the industry, Dr. Izumo was Professor of Medicine, Harvard Medical School and Director of Cardiovascular Research, Beth Israel Deaconess Medical Center, Boston, and Chief of Cardiology Division, Professor of Internal Medicine & Biological Chemistry and Director of the Center for Organogenesis, University of Michigan Medical School. Dr. Izumo graduated from University of Tokyo and received clinical and research trainings at Harvard-affiliated Beth Israel Hospital and The Children’s Hospital, Boston. He is a board-certified physician in internal medicine and cardiovascular disease.